Moshe Talpaz
Impact in
- Hematology top 0.01%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 609
- Chronic Myeloid Leukemia Treatments 519
- Acute Myeloid Leukemia Research 144
- Genetics 495
- Chronic Lymphocytic Leukemia Research 359
- Myeloproliferative Neoplasms: Diagnosis and Treatment 142
- Co-authors
- Hagop M. KantarjianRazelle KurzrockJörge E. CortesCharles L. SawyersBrian DrukerDebra RestaRenaud CapdevilleZeev Estrov
- Journals
- Blood (240 papers)Journal of Clinical Oncology (79 papers)Cancer (67 papers)Leukemia (26 papers)British Journal of Haematology (17 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Moshe Talpaz
759 papers receiving 43.4k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Hematology 29.2k
- Genetics 22.8k
- Rheumatology 13.1k
- Oncology 8.7k
- Pathology and Forensic Medicine 4.6k
Countries citing papers authored by Moshe Talpaz
This map shows the geographic impact of Moshe Talpaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Talpaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Talpaz more than expected).
Fields of papers citing papers by Moshe Talpaz
This network shows the impact of papers produced by Moshe Talpaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Talpaz. The network helps show where Moshe Talpaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Moshe Talpaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2019 | 36 | |
| 9 | 2018 | 3 | |
| 10 | 2015 | 75 | |
| 11 | 2011 | 310 | |
| 12 | 2010 | 317 | |
| 13 | 2007 | 160 | |
| 14 | 2005 | 1 | |
| 15 | 2003 | 13 | |
| 16 | Significance of FHIT expression in chronic myelogenous leukemia. | 1999 | 9 |
| 17 | Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture. | 1997 | 10 |
| 18 | 1991 | 15 | |
| 19 | Treatment of acute myelogenous leukemia with chemotherapy and hematopoietic growth factors | 1990 | 2 |
| 20 | 1989 | 21 |
About Moshe Talpaz
Moshe Talpaz is a scholar working on Hematology, Genetics, Rheumatology, Pathology and Forensic Medicine and Oncology, having authored 778 papers that have together received 44.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (519 papers), Chronic Lymphocytic Leukemia Research (359 papers), Eosinophilic Disorders and Syndromes (203 papers), Acute Myeloid Leukemia Research (144 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (142 papers), Acute Lymphoblastic Leukemia research (82 papers), Lymphoma Diagnosis and Treatment (81 papers) and Cytokine Signaling Pathways and Interactions (42 papers). The work is most often cited by research in Hematology (29.2k citations), Genetics (22.8k citations), Rheumatology (13.1k citations), Oncology (8.7k citations) and Pathology and Forensic Medicine (4.6k citations). Moshe Talpaz has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Hagop M. Kantarjian, Razelle Kurzrock, Jörge E. Cortes, Charles L. Sawyers, Brian Druker, Debra Resta, Renaud Capdeville, Zeev Estrov, Stefan Faderl and Jordan U. Gutterman. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Leukemia and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.